Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 1 in 5 Russian Doctors Ready for COVID-19 Vaccination after Industrial Production Is Launched

Wednesday, August 19, 2020

19% of doctors say that they will definitely get vaccinated against coronavirus after such an opportunity arises, according to a survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Interestingly, a significant part of those who chose to write their own answer (4%) said they refuse to vaccinate due to a previous illness. Another 11% are ready to get vaccinated only if it is a prerequisite for the job, and 15% would like to first learn the experience of their colleagues who will act as pioneers before being vaccinated themselves.

While 40% of the respondents do not plan to get vaccinated, they will not dissuade others either. Out of almost 200 specialists who chose this answer, there was only 1 infectious disease specialist and only 6 resuscitation doctors.

11% of the respondents actively opposed the idea. They not only will not get vaccinated themselves, but also plan to dissuade others from getting vaccinated.

Will you be vaccinated against COVID-19 if the Russian vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology goes into circulation between August and September? (single-answer question)